Prime Medicine Inc (PRME)
3.345
-0.25
(-6.95%)
USD |
NASDAQ |
Nov 15, 16:00
3.34
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2024
--
Maximum
Mar 2024
--
Average
--
Median
Mar 2024
Debt to Equity Ratio Benchmarks
| Bristol-Myers Squibb Co | 2.902 |
| Molecular Templates Inc | 0.00 |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.4322 |
| IGC Pharma Inc | 0.0173 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 332.78M |
| Total Liabilities (Quarterly) | 143.28M |
| Shareholders Equity (Quarterly) | 189.50M |
| Current Ratio | 6.497 |